Cartesian Therapeutics Inc. (RNAC) — Long-term Investment Intensity
Cartesian Therapeutics Inc. (RNAC) has a Long-term Investment Intensity of 0.5% as of September 2025. Long-term investments of $2.00 Million represent 0.5% of total assets of $372.68 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. For the complete balance sheet picture, see balance sheet size of Cartesian Therapeutics Inc..
LT Investment Intensity
Long-term Investments
Total Assets
Country
Cartesian Therapeutics Inc. Long-term Investment Intensity (2021–2024)
This chart shows how Cartesian Therapeutics Inc.'s Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 0.5%, reflecting long-term investments of $2.00 Million against total assets of $372.68 Million USD. See working capital position of Cartesian Therapeutics Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Long-term Investment Intensity for Cartesian Therapeutics Inc. (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Cartesian Therapeutics Inc. from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Cartesian Therapeutics Inc. (RNAC) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.5% | $2.00 Million | $435.02 Million | ▼ -0.2 pp |
| 2023 | 0.7% | $2.00 Million | $305.05 Million | ▼ -0.6 pp |
| 2022 | 1.2% | $2.00 Million | $165.89 Million | ▼ 0.0 pp |
| 2021 | 1.3% | $2.00 Million | $159.88 Million | — |